Correlation Between Vera Therapeutics and Equillium

Can any of the company-specific risk be diversified away by investing in both Vera Therapeutics and Equillium at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vera Therapeutics and Equillium into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Vera Therapeutics and Equillium, you can compare the effects of market volatilities on Vera Therapeutics and Equillium and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vera Therapeutics with a short position of Equillium. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vera Therapeutics and Equillium.

Diversification Opportunities for Vera Therapeutics and Equillium

-0.49

Correlation Coefficient

Vera Therapeutics  Equillium

Very good diversification

The 3 months correlation between Vera and Equillium is -0.49. Overlapping area represents the amount of risk that can be diversified away by holding Vera Therapeutics and Equillium in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Equillium and Vera Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vera Therapeutics are associated (or correlated) with Equillium. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Equillium has no effect on the direction of Vera Therapeutics i.e., Vera Therapeutics and Equillium go up and down completely randomly.

Pair Corralation between Vera Therapeutics and Equillium

Given the investment horizon of 90 days Vera Therapeutics is expected to generate 0.5 times more return on investment than Equillium. However, Vera Therapeutics is 2.01 times less risky than Equillium. It trades about 0.13 of its potential returns per unit of risk. Equillium is currently generating about -0.01 per unit of risk. If you would invest  3,836  in Vera Therapeutics on September 3, 2024 and sell it today you would earn a total of  1,139  from holding Vera Therapeutics or generate 29.69% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Vera Therapeutics  vs.  Equillium

Vera Therapeutics

Risk-Adjusted Performance

9 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Vera Therapeutics are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat unsteady basic indicators, Vera Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

Equillium

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Equillium has generated negative risk-adjusted returns adding no value to investors with long positions. Even with relatively invariable basic indicators, Equillium is not utilizing all of its potentials. The latest stock price agitation, may contribute to short-term losses for the retail investors.

Pair Trading with Vera Therapeutics and Equillium

The main advantage of trading using opposite Vera Therapeutics and Equillium positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vera Therapeutics position performs unexpectedly, Equillium can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Equillium will offset losses from the drop in Equillium's long position.

The idea behind Vera Therapeutics and Equillium pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.